Find uplifting stories about heroes, innovations, and solutions
71 results for "alzheimer's disease"
Scientists discovered that tau, the protein linked to Alzheimer's disease, plays a crucial role in creating memories that last. The finding could reshape how we treat dementia in the future.
Vanderbilt researchers developed two breakthrough compounds that let scientists study TAOK proteins for the first time, opening new paths to understanding and potentially treating Alzheimer's disease. More than seven million Americans with Alzheimer's now have new hope for future treatments.
Researchers discovered a molecular switch that drives harmful brain inflammation in Alzheimer's disease, and turning it off protected brain connections in mice. The finding could lead to new treatments that calm overactive immune responses without blocking normal defenses.
New research shows people who eat eggs regularly have a significantly lower risk of developing Alzheimer's disease, with the most frequent egg-eaters seeing up to a 27% reduction. At around $2 per dozen, this breakfast staple could be an affordable addition to your brain health strategy.
Scientists discovered why women face twice the risk of Alzheimer's disease as men, and the breakthrough points to a promising new treatment approach. The hidden space between brain cells becomes vulnerable when estrogen drops during menopause.
Banner Health is testing whether combination medications can stop Alzheimer's before it starts in people with high genetic risk. The Arizona research hub is giving local families access to breakthrough treatments years before they reach the rest of the country.
Women's superior verbal memory helps their brains compensate for Alzheimer's damage longer than men's, but this advantage means they get diagnosed and treated years too late. New research shows women pass standard memory tests for nearly three years longer despite having the same brain pathology as men.
Two major health companies are using artificial intelligence to redesign clinical trials, potentially bringing breakthrough treatments to patients years faster. The collaboration focuses on cancers and Alzheimer's disease, using real patient data to find who benefits most from new medicines.
A new blood test approved in Europe can detect Alzheimer's disease with a simple draw, replacing invasive spinal taps and costly brain scans. The breakthrough promises faster diagnosis for millions of families facing the uncertainty of dementia.
A major 15-year study of nearly 40,000 older adults found that eating at least five eggs per week was linked to a 27% lower risk of developing Alzheimer's disease. The protective effect held up even after accounting for lifestyle factors, other health conditions, and overall diet quality.
A major 15-year study finds that eating just one egg daily could reduce your risk of Alzheimer's disease by up to 27%. The research offers new hope for preventing one of the most feared conditions of aging through a simple dietary change.
Chemical engineering student Ashley Blake just earned one of America's most prestigious undergraduate honors for her work developing treatments that could help millions living with Alzheimer's and Parkinson's. The Goldwater Scholar is creating drug delivery systems that can break through the brain's natural barriers to deliver medicine where it's needed most.
Health Canada has authorized Kisunla, a breakthrough treatment that slows early Alzheimer's progression by 22% and can be stopped once brain plaques clear. Over 770,000 Canadians living with Alzheimer's now have access to the first disease-modifying therapy that targets the root cause of memory loss.
Scientists at Baylor College of Medicine discovered how to activate the brain's own cleaning crew to fight Alzheimer's disease. By boosting a single protein, they helped mice with memory problems clear harmful plaques and preserve brain function.
Millions of Alzheimer's patients who experience severe agitation now have a safer treatment option after the FDA approved Auvelity, a drug that works differently than risky antipsychotic medications. The approval gives hope to families struggling with one of the disease's most challenging symptoms.
Millions of families caring for loved ones with Alzheimer's just got meaningful help. The FDA has approved AXS-05, the first treatment specifically designed to ease agitation in Alzheimer's patients.
Researchers have discovered that blocking a single protein called PTP1B improved memory and helped clear brain plaque in mice with Alzheimer's disease. The breakthrough could lead to treatments that tackle multiple aspects of the disease at once.
Researchers discovered how to turn off a molecular trigger that fuels damaging brain inflammation in Alzheimer's disease. The breakthrough could lead to treatments that protect memory without weakening the immune system.
While expensive new Alzheimer's drugs grab headlines, doctors reveal that existing affordable medications work twice as well but only half of patients receive them. Researchers are now combining different approaches that could finally stop the disease.
South Korean scientists just solved a major obstacle blocking simple blood tests for Alzheimer's disease. Their breakthrough sensor can detect disease markers even in real blood samples.
Showing 20 of 71